Advisory Committees

November 13, 2013: Vaccines and Related Biological Products Advisory Committee Meeting Draft Agenda

Food and Drug Administration
Center for Biologics Evaluation and Research
Vaccines and Related Biological Products Advisory Committee
134th Meeting via Teleconference
Rockwall II, Conference Room 1033
5515 Security Lane, Rockville, MD
November 13, 2013

DRAFT AGENDA

AgendaOpen Session
12:30 p.m.Call to Order and Opening Remarks
Robert Daum, M.D., Chair

Conflict of Interest Statement
Donald Jehn, M.S., FDA
12:40 p.m.Acknowledgement of Retiring Members
Marion Gruber, Ph.D., FDA
Topic I

Presentation of Laboratory of Retroviruses and Laboratory of Immunoregulation, Division of Viral Products, Office of Vaccines Research and Review, Center for Biologics Evaluation and Research
12:50Overview of Research/Site Visit Process,
Center Biologics Evaluation and Research (CBER)
Carolyn Wilson, Ph.D., FDA 
1:10Overview Division of Viral Products, OVRR
Jerry Weir, Ph.D., FDA
1:25Overview Laboratory of Retroviruses
Hana Golding, Ph.D., FDA
1:50Overview Laboratory of Immunoregulation
Carol Weiss, MD, Ph.D., FDA
2:10Open Public Hearing (if no speakers, will move directly to closed session)
3:10Closed Session
3:45Adjourn Meeting

Page Last Updated: 08/19/2015
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.